Hanna Kuusisto

624 total citations
42 papers, 429 citations indexed

About

Hanna Kuusisto is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Hanna Kuusisto has authored 42 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 9 papers in Neurology. Recurrent topics in Hanna Kuusisto's work include Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (9 papers) and Peripheral Neuropathies and Disorders (7 papers). Hanna Kuusisto is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (9 papers) and Peripheral Neuropathies and Disorders (7 papers). Hanna Kuusisto collaborates with scholars based in Finland, Austria and Netherlands. Hanna Kuusisto's co-authors include Irina Elovaara, Terho Lehtimäki, Merja Soilu‐Hänninen, Sari Atula, Eeva Moilanen, Katriina Vuolteenaho, Aki Hietaharju, Tapani Keränen, R. Nieminen and Sini M. Laakso and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Emergency Medicine and Journal of Neuroimmunology.

In The Last Decade

Hanna Kuusisto

31 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanna Kuusisto Finland 13 249 126 102 81 78 42 429
Victoria Fernández Spain 13 302 1.2× 118 0.9× 93 0.9× 82 1.0× 91 1.2× 40 483
C. A. Vedeler Norway 11 229 0.9× 72 0.6× 79 0.8× 108 1.3× 72 0.9× 13 442
José Manuel García‐Domínguez Spain 14 346 1.4× 102 0.8× 79 0.8× 132 1.6× 51 0.7× 52 609
Jacqueline Nicholas United States 12 370 1.5× 108 0.9× 67 0.7× 110 1.4× 86 1.1× 47 507
Carrie M. Hersh United States 13 465 1.9× 135 1.1× 61 0.6× 150 1.9× 111 1.4× 51 588
Brandon Beaber United States 8 458 1.8× 57 0.5× 141 1.4× 115 1.4× 101 1.3× 12 640
Sibyl Wray United States 14 442 1.8× 157 1.2× 219 2.1× 175 2.2× 100 1.3× 58 628
Jonathan Hosey United States 3 433 1.7× 121 1.0× 41 0.4× 127 1.6× 89 1.1× 5 505
Michael Haboubi Canada 2 433 1.7× 121 1.0× 41 0.4× 123 1.5× 89 1.1× 3 501
Nils Koch-Henriksen Denmark 12 537 2.2× 118 0.9× 161 1.6× 130 1.6× 172 2.2× 16 706

Countries citing papers authored by Hanna Kuusisto

Since Specialization
Citations

This map shows the geographic impact of Hanna Kuusisto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Kuusisto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Kuusisto more than expected).

Fields of papers citing papers by Hanna Kuusisto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Kuusisto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Kuusisto. The network helps show where Hanna Kuusisto may publish in the future.

Co-authorship network of co-authors of Hanna Kuusisto

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Kuusisto. A scholar is included among the top collaborators of Hanna Kuusisto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Kuusisto. Hanna Kuusisto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kuusisto, Hanna, et al.. (2025). Patient Generated Digital Health Data: An Example from the Finnish Neuro Registry. Studies in health technology and informatics. 323. 174–178.
3.
Hämäläinen, Päivi, Merja Soilu‐Hänninen, Hanna Kuusisto, et al.. (2025). Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registry. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(1). 3120688298–3120688298.
4.
Kuusisto, Hanna, et al.. (2025). Clinical characteristics of multiple sclerosis in older adults in a Finnish Tertiary Centre. Clinical Neurology and Neurosurgery. 258. 109164–109164.
5.
Turja, Tuuli, et al.. (2025). Beyond early and late adopters: Reimagining health technology readiness through health-related circumstances. Sustainable Futures. 10. 101003–101003.
6.
Turja, Tuuli, et al.. (2024). Shared decision-making in healthcare: development and assessment of the translated Finnish version of the SDM-Q-9. Scandinavian Journal of Public Health. 53(7). 713–720.
8.
Kuusisto, Hanna, et al.. (2024). MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis. International Journal of MS Care. 26(Q4). 273–280. 4 indexed citations
9.
Verkkoniemi‐Ahola, Auli, Päivi Hartikainen, Hanna Kuusisto, et al.. (2023). Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(4). 3100567666–3100567666. 1 indexed citations
10.
Kuusisto, Hanna, et al.. (2023). Neurologists’ Experiences and Attitudes Towards Teleneurology – Has Covid-19 Pandemic Made a Difference?. Studies in health technology and informatics. 309. 210–214. 1 indexed citations
11.
Jylhä, Virpi, et al.. (2022). Patient-generated data in epilepsy care decisions: a scoping review protocol. JBI Evidence Synthesis. 20(6). 1578–1584. 2 indexed citations
12.
Kuusisto, Hanna, et al.. (2022). Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study. Multiple Sclerosis and Related Disorders. 61. 103755–103755. 28 indexed citations
13.
Atula, Sari, et al.. (2021). Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study. Journal of Neurology. 269(2). 913–922. 23 indexed citations
14.
Saranto, Kaija, et al.. (2020). Patient Awareness of the Severity of Their Information and Medication Management-Related Adverse Events. Studies in health technology and informatics. 272. 63–66.
16.
Kuusisto, Hanna, et al.. (2008). Apoptosis-related molecules in blood in multiple sclerosis. Journal of Neuroimmunology. 205(1-2). 135–141. 29 indexed citations
17.
Kuusisto, Hanna, Mari Levula, Terho Lehtimäki, et al.. (2006). Gene expression profiles in Finnish twins with multiple sclerosis. BMC Medical Genetics. 7(1). 11–11. 23 indexed citations
18.
Kuusisto, Hanna, et al.. (2005). Enteroviruses and the risk of MS in the Finnish Twin Cohort. European Journal of Neurology. 12(9). 707–709. 4 indexed citations
19.
Wu, Xingchen, Prasun Dastidar, Hanna Kuusisto, et al.. (2005). Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS. Acta Neurologica Scandinavica. 112(4). 242–247. 14 indexed citations
20.
Hietaharju, Aki, et al.. (2003). [Cases of oculopharyngeal muscular dystrophy even in Finland].. PubMed. 119(7). 625–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026